Sylvia Haas Selected Research

Sylvia Haas Research Topics

45	Venous Thromboembolism 08/2022 - 05/2003
43	Atrial Fibrillation 06/2022 - 07/2003
42	Hemorrhage 08/2022 - 05/2003
35	Stroke (Strokes) 01/2022 - 07/2003
16	Venous Thrombosis (Deep-Vein Thrombosis) 04/2019 - 05/2003
10	Embolism (Embolus) 01/2022 - 01/2014
8	Pulmonary Embolism 07/2017 - 10/2005
7	Neoplasms (Cancer) 02/2021 - 10/2005
7	Acute Coronary Syndrome 01/2020 - 05/2003
5	Heart Failure 02/2021 - 02/2011
5	Thromboembolism 02/2021 - 06/2013
4	Thrombosis (Thrombus) 01/2022 - 02/2012
4	Hypertension (High Blood Pressure) 02/2021 - 12/2017
3	Vascular Diseases (Vascular Disease) 02/2021 - 12/2019
3	Coronary Artery Disease (Coronary Atherosclerosis) 01/2020 - 07/2003
3	Wounds and Injuries (Trauma) 08/2016 - 04/2007
3	Thrombocytopenia (Thrombopenia) 04/2016 - 10/2002
2	Diabetes Mellitus 02/2021 - 12/2019
2	Kidney Diseases (Kidney Disease) 01/2019 - 06/2013
1	Uterine Hemorrhage (Uterine Bleeding) 08/2022
1	Pneumonia (Pneumonitis) 08/2022
1	COVID-19 08/2022
1	Critical Illness (Critically Ill) 08/2022
1	Overweight 12/2021
1	Anemia 01/2021
1	Cardiomyopathies (Cardiomyopathy) 01/2019
1	Chronic Renal Insufficiency 01/2019
1	Lung Neoplasms (Lung Cancer) 06/2017
1	Urogenital Neoplasms 06/2017
1	Hematoma 01/2016
1	Renal Insufficiency (Renal Failure) 04/2012
1	Body Weight (Weight, Body) 08/2003
1	Thrombotic Stroke 02/2003
1	Transient Ischemic Attack 02/2003

42	AnticoagulantsIBA 08/2022 - 05/2009
34	RivaroxabanIBA 03/2021 - 08/2006
23	Vitamin K FDA Link 01/2022 - 01/2004
11	Enoxaparin (Lovenox)FDA LinkGeneric 08/2022 - 11/2006
10	Heparin (Liquaemin)FDA LinkGeneric 07/2017 - 10/2002
9	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 08/2022 - 05/2003
8	Factor Xa InhibitorsIBA 02/2021 - 01/2007
6	certoparin (certoparin sodium)IBA 07/2011 - 08/2003
3	AntithrombinsIBA 02/2021 - 01/2004
3	N(4)-oleylcytosine arabinosideIBA 02/2021 - 12/2017
3	Fondaparinux (Arixtra)FDA Link 02/2019 - 08/2006
2	Pharmaceutical PreparationsIBA 04/2016 - 01/2014
2	Warfarin (Coumadin)FDA LinkGeneric 01/2014 - 01/2004
2	Thrombin FDA Link 04/2012 - 01/2004
2	ximelagatran (Exanta)IBA 01/2004 - 07/2003
1	COVID-19 VaccinesIBA 08/2022
1	Acetaminophen (Paracetamol)FDA LinkGeneric 01/2020
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 01/2019
1	CreatinineIBA 07/2017
1	ORALIT (ORS)IBA 04/2016
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 04/2016
1	Factor Xa (Coagulation Factor Xa)IBA 01/2014
1	Dabigatran FDA Link 04/2012
1	Factor VIIa (Activated Factor VII)IBA 04/2007
1	idraparinuxIBA 08/2006
1	Biomarkers (Surrogate Marker)IBA 10/2005
1	reviparin (reviparin-sodium)IBA 03/2004
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 07/2003
1	HirudinsIBA 05/2003
1	Platelet Factor 4IBA 10/2002
1	AntibodiesIBA 10/2002

27	Therapeutics 12/2021 - 02/2003
4	Hip Replacement Arthroplasty (Total Hip Replacement) 09/2008 - 11/2006
3	Orthopedic Procedures 03/2016 - 03/2004
2	Operative Surgical Procedures 08/2016 - 04/2016
2	Secondary Prevention 01/2016 - 05/2009
1	Central Venous Catheters 08/2019
1	Percutaneous Coronary Intervention 01/2019
1	Catheter Ablation 01/2018
1	Electric Countershock (Cardioversion) 01/2018
1	Early Ambulation 08/2016
1	Anesthesia 01/2016
1	Indwelling Catheters (Indwelling Catheter) 06/2013
1	Ambulatory Surgical Procedures (Outpatient Surgery) 06/2012
1	Knee Replacement Arthroplasty (Total Knee Replacement) 01/2012
1	Long-Term Care 04/2008
1	Intravenous Administration 01/2008